100 related articles for article (PubMed ID: 3670536)
1. [Clinical effects of lipo-prostaglandin E1 in patients with delayed cerebral vasospasm].
Korosue K; Izawa I; Hamano S; Ishida K; Kurihara E; Nagao T; Tamaki N; Matsumoto S
No Shinkei Geka; 1987 Jun; 15(6):635-40. PubMed ID: 3670536
[TBL] [Abstract][Full Text] [Related]
2. [Lipo prostaglandin E1 administration in the acute stage following subarachnoid hemorrhage].
Korosue K; Kondoh T; Ishikawa A; Suzuki H; Nagao T; Tamaki N; Matsumoto S
No Shinkei Geka; 1988; 16(5 Suppl):509-15. PubMed ID: 3399005
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and hemodynamic effects of lipo PGE1 in cerebral infarction].
Korosue K; Kondoh T; Ishikawa A; Suzuki H; Nagao T; Tamaki N; Matsumoto S
No Shinkei Geka; 1988 Jun; 16(7):819-26. PubMed ID: 3221965
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of intravenous administration of lipo-prostaglandin E1 on the ischemic gastric tube in pigs.
Tobari S; Ikeda Y; Takami H
J Surg Res; 2005 Nov; 129(1):79-84. PubMed ID: 16087193
[TBL] [Abstract][Full Text] [Related]
5. [Intracavernous injection of lipo prostaglandin E1 for the diagnosis of impotence: a comparative study with prostaglandin E1-CD].
Yajima M; Baba K; Minagawa N; Kohno S; Haraguchi C; Iwamoto T; Osada T
Hinyokika Kiyo; 1993 Mar; 39(3):289-92. PubMed ID: 8506803
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality.
Akahori H; Takamura T; Hayakawa T; Ando H; Yamashita H; Kobayashi K
Diabetes Res Clin Pract; 2004 Jun; 64(3):153-9. PubMed ID: 15126001
[TBL] [Abstract][Full Text] [Related]
7. Progress in the prostaglandin E1-therapy of the intermittent claudication by means of bolus injections of LIPO-prostaglandin E1 (LIPO-PGE1).
Scheffler P; Gross J; Markwirth T; Maier J; Schieffer H
Eur J Clin Pharmacol; 1996; 51(3-4):235-9. PubMed ID: 9010691
[TBL] [Abstract][Full Text] [Related]
8. Admission angiographic cerebral circulation time may predict subsequent angiographic vasospasm after aneurysmal subarachnoid hemorrhage.
Udoetuk JD; Stiefel MF; Hurst RW; Weigele JB; LeRoux PD
Neurosurgery; 2007 Dec; 61(6):1152-9; discussion 1159-61. PubMed ID: 18162893
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E1 incorporated in lipid microspheres (lipo PGE1).
Otomo S; Mizushima Y; Aihara H; Yokoyama K; Watanabe M; Yanagawa A
Drugs Exp Clin Res; 1985; 11(9):627-31. PubMed ID: 3880049
[TBL] [Abstract][Full Text] [Related]
10. The effect of prostaglandin E1 on local cerebral blood flow during cerebral-aneurysm clip ligation.
Abe K; Fujino Y; Demizu A; Takauchi Y; Hoshida T; Kamada K; Mashimo T; Yoshiya I
Eur J Anaesthesiol; 1991 Sep; 8(5):359-63. PubMed ID: 1935924
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E1 incorporated in lipid microspheres in the treatment of peripheral vascular diseases and diabetic neuropathy.
Hoshi K; Mizushima Y; Kiyokawa S; Yanagawa A
Drugs Exp Clin Res; 1986; 12(8):681-5. PubMed ID: 3757764
[TBL] [Abstract][Full Text] [Related]
12. A multicenter double blind controlled study of lipo-PGE1, PGE1 incorporated in lipid microspheres, in peripheral vascular disease secondary to connective tissue disorders.
Mizushima Y; Shiokawa Y; Homma M; Kashiwazaki S; Ichikawa Y; Hashimoto H; Sakuma A
J Rheumatol; 1987 Feb; 14(1):97-101. PubMed ID: 3553591
[TBL] [Abstract][Full Text] [Related]
13. Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage.
Ekelund A; Reinstrup P; Ryding E; Andersson AM; Molund T; Kristiansson KA; Romner B; Brandt L; Säveland H
Acta Neurochir (Wien); 2002 Jul; 144(7):703-12; discussion 712-3. PubMed ID: 12181704
[TBL] [Abstract][Full Text] [Related]
14. Effects of lipo-prostaglandin E1 on wound bed microcirculation.
Hasegawa H; Ichioka S
J Wound Care; 2015 Jul; 24(7):293-4, 296, 298-9. PubMed ID: 26198551
[TBL] [Abstract][Full Text] [Related]
15. [Effects of controlled hypotension induced by prostaglandin E1 on the cerebral blood flow].
Sha K; Miyata Y; Nagahata T; Hashizume K; Ueda Y; Hiraki N
Masui; 1990 Feb; 39(2):138-43. PubMed ID: 2325248
[TBL] [Abstract][Full Text] [Related]
16. Intraarterial infusion of papaverine and change of cerebral hemodynamics in symptomatic cerebral vasospasm.
Minami H; Kuwamura K; Tamaki N
Kobe J Med Sci; 2001 Aug; 47(4):169-79. PubMed ID: 11733656
[TBL] [Abstract][Full Text] [Related]
17. [Angiographic vasospasm and regional cerebral blood flow in the cases of ruptured aneurysm --Correlation between vasospasm in the middle cerebral artery and delayed ischemic hemiparesis (author's transl)].
Matsuzaki T; Mizukami M; Kawase T; Tazawa T
No Shinkei Geka; 1981 Dec; 9(13):1511-6. PubMed ID: 7345380
[TBL] [Abstract][Full Text] [Related]
18. Effects of intravenous lipoprostaglandin E1 on neurogenic intermittent claudication.
Murakami M; Takahashi K; Sekikawa T; Yasuhara K; Yamagata M; Moriya H
J Spinal Disord; 1997 Dec; 10(6):499-504. PubMed ID: 9438815
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the dopamine induced hypertension therapy for vasospasm (author's transl)].
Haraguchi S; Ebina K
No Shinkei Geka; 1982 Mar; 10(3):279-89. PubMed ID: 7099370
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the effect of Lipo PGE1 and other related compounds on experimental peripheral arterial occlusive disease in rats.
Goto J; Araki H; Otomo S; Aihara H
Drugs Exp Clin Res; 1986; 12(11):917-21. PubMed ID: 3816509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
